Unlock stock picks and a broker-level newsfeed that powers Wall Street.

LSE - Delayed Quote GBp

MaxCyte, Inc. (MXCT.L)

212.20
-2.80
(-1.30%)
As of 8:26:19 AM GMT+1. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
38,627
38,627
41,288
44,261
33,894.10
Cost of Revenue
7,100
7,100
4,742
5,098
3,647.40
Gross Profit
31,527
31,527
36,546
39,163
30,246.70
Operating Expense
82,724
82,724
84,845
66,524
48,435.30
Operating Income
-51,197
-51,197
-48,299
-27,361
-18,188.60
Net Non Operating Interest Income Expense
10,142
10,142
10,376
3,917
-893.60
Other Income Expense
--
--
--
-127
--
Pretax Income
-41,055
-41,055
-37,923
-23,571
-19,082.20
Net Income Common Stockholders
-41,055
-41,055
-37,923
-23,571
-19,082.20
Diluted NI Available to Com Stockholders
-41,055
-41,055
-37,923
-23,571
-19,082.20
Basic EPS
-0.34
-0.39
-0.37
-0.23
-0.21
Diluted EPS
-0.34
-0.39
-0.37
-0.23
-0.21
Basic Average Shares
104,388.01
104,849.22
103,268.50
101,702.66
90,619.06
Diluted Average Shares
104,388.01
104,849.22
103,268.50
101,702.66
90,619.06
Total Operating Income as Reported
-51,197
-51,197
-48,299
-27,361
-18,188.60
Total Expenses
89,824
89,824
89,587
71,622
52,082.70
Net Income from Continuing & Discontinued Operation
-41,055
-41,055
-37,923
-23,571
-19,082.20
Normalized Income
-41,055
-41,055
-37,923
-23,571
-19,082.20
Interest Income
10,142
10,142
10,376
3,917
150.80
Interest Expense
116
--
--
126.90
1,044.40
Net Interest Income
10,142
10,142
10,376
3,917
-893.60
EBIT
-51,197
-51,197
-48,299
-27,361
-18,037.80
EBITDA
-46,407
-46,407
-43,733
-24,663
-16,613.90
Reconciled Cost of Revenue
6,453
6,453
4,161
4,928
3,572.60
Reconciled Depreciation
4,790
4,790
4,566
2,698
1,423.90
Net Income from Continuing Operation Net Minority Interest
-41,055
-41,055
-37,923
-23,571
-19,082.20
Normalized EBITDA
-46,407
-46,407
-43,733
-24,663
-16,613.90
12/31/2021 - 3/29/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

EKF.L EKF Diagnostics Holdings plc
21.70
+5.85%
 
CTKB Cytek Biosciences, Inc.
3.8600
+2.39%
 
OWLT Owlet, Inc.
3.9400
+4.51%
 
SN.L Smith & Nephew plc
993.20
-0.48%
 
UFPT UFP Technologies, Inc.
209.80
+1.45%
 
CODX Co-Diagnostics, Inc.
0.3711
+6.06%
 
BRKR Bruker Corporation
39.66
+1.51%
 
BIO Bio-Rad Laboratories, Inc.
240.17
-1.01%
 
RBOT Vicarious Surgical Inc.
8.46
-0.12%
 
QSI Quantum-Si incorporated
1.2100
-1.63%